09/05/2024
7:27 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
7:24 PM | Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:57 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
7:04 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
7:08 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
10:33 AM | Corcept Therapeutics (Subject)
Guyer William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024
4:59 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/26/2024
2:37 PM | Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024
6:10 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
5:31 PM | Corcept Therapeutics (Issuer)
Hunt Hazel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
5:56 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2024
3:42 PM | BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
12:36 PM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
10:26 AM | Corcept Therapeutics (Subject)
Guyer William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/29/2024
3:13 PM | Corcept Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/03/2024
4:13 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
4:16 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
3:54 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
3:54 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
12:54 PM | Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2024
12:46 PM | Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2024
12:30 PM | Corcept Therapeutics (Subject)
Guyer William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2024
9:16 AM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024
5:47 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
5:21 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
8:19 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
8:10 PM | Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
8:11 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
8:13 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
8:15 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
8:15 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
1:15 PM | Corcept Therapeutics (Subject)
Guyer William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
1:05 PM | Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
12:05 PM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024
3:38 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:38 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:38 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:39 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:40 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:41 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:43 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad) WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock
This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race… Click here to see a unique election-year trade |
05/31/2024
3:44 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:45 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:46 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:47 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:01 PM | Corcept Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/30/2024
8:00 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
7:03 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
6:53 PM | Corcept Therapeutics (Issuer)
WILSON JAMES N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
12:14 PM | Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
12:22 PM | Corcept Therapeutics (Subject)
Guyer William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/21/2024
5:41 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
5:42 PM | Corcept Therapeutics (Issuer)
Murray Joshua M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
5:47 PM | Corcept Therapeutics (Issuer)
Park Kimberly (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
5:25 PM | Cannon Gillian (Reporting)
Corcept Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
5:25 PM | BAKER G LEONARD JR (Reporting)
Corcept Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
5:28 PM | Corcept Therapeutics (Issuer)
MAHONEY DAVID L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
5:30 PM | Alton Gregg H (Reporting)
Corcept Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
5:08 PM | Corcept Therapeutics (Issuer)
WILSON JAMES N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
7:32 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
8:32 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
11:24 AM | Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024
11:35 AM | Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/06/2024
7:23 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
3:05 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
10:39 AM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/18/2024
4:09 PM | Corcept Therapeutics (Filer)
| Form DEFA14A | |
04/17/2024
3:44 PM | Corcept Therapeutics (Filer)
| Form ARS | |
04/17/2024
5:05 AM | Corcept Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2024
6:00 PM | Corcept Therapeutics (Issuer)
MAHONEY DAVID L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:43 PM | Corcept Therapeutics (Filer)
| Form DEF 14A | |
04/08/2024
5:16 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
11:40 AM | Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024
7:00 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
6:38 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
9:03 AM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/29/2024
1:12 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
1:32 PM | Corcept Therapeutics (Subject)
INGALLS & SNYDER LLC (Filed by)
| Form SC 13G/A | |
03/27/2024
12:01 PM | Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
4:09 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
8:14 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
8:19 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
8:02 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
8:03 PM | Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
8:09 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:41 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:24 PM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
8:11 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
7:06 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
11:12 AM | Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/15/2024
3:17 PM | Corcept Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
Biden’s Capital Gains Tax to Devastate Savings! (Ad) Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security. >> Get Your FREE Wealth Protection Guide << |
02/15/2024
2:45 PM | Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
3:23 PM | BAKER G LEONARD JR (Filed by)
Corcept Therapeutics (Subject)
| Form SC 13G/A | |
02/13/2024
7:47 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:25 PM | BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
6:59 PM | Corcept Therapeutics (Issuer)
Hunt Hazel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:08 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:20 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
6:38 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
6:40 PM | Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
